40251 - 8th Tumor Models San Francisco Summit 2024
Evvnt Promotion / evvnt
Archive
30.01.2024 - 01.02.2024 Grand Hyatt At SFO, 55 South Mcdonnell Road, 94128 San Francisco, California, USA
Time: 09:00 - 17:00
Conference themes
Following Merck announcing their goal to phase out animal use in their work, Astellas and MIMETAS expanding their partnership in immunotherapeutic development, and the domino effects across the field caused by the FDA Modernization Act 2.0, 2023 has set an exciting precedent for the upcoming year.
Following Merck announcing their goal to phase out animal use in their work, Astellas and MIMETAS expanding their partnership in immunotherapeutic development, and the domino effects across the field caused by the FDA Modernization Act 2.0, 2023 has set an exciting precedent for the upcoming year.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Notes
Brochure: https://go.evvnt.com/1948808-0?pid=4832
Speakers: Alba Gonzalez-Junca - Associate Director - Arsenal Biosciences, Aldo Pourchet - Chief Executive Officer and Co-Founder - Omios Biologics, and more.
Brochure: https://go.evvnt.com/1948808-0?pid=4832
Speakers: Alba Gonzalez-Junca - Associate Director - Arsenal Biosciences, Aldo Pourchet - Chief Executive Officer and Co-Founder - Omios Biologics, and more.
Enquiries and Registration:
https://go.evvnt.com/1948808-2?pid=4832
Ms. Anita Keleman
General Medicine
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
